← Open Payments lookup

MUHAMMAD SHAMSI: Open Payments

NPI 1609843721 · PLYMOUTH MEETING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,191 in 66 payments from 17 companies in 2025. Trend: 2023 $7,871 · 2024 $3,126 · 2025 $1,191

Food & beverage: $1,191
CompanyPaymentsAmount
ABBVIE INC.27$205
Otsuka America Pharmaceutical, Inc.7$170
E.R. Squibb & Sons, L.L.C.4$161
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$99
Vanda Pharmaceuticals Inc.3$85
Alkermes, Inc.3$70
Janssen Pharmaceuticals, Inc3$68
Tris Pharma Inc3$60
Neurocrine BioSciences, Inc.2$55
Almatica Pharma LLC2$47

Products named: VRAYLAR, REXULTI, COBENFY, CAPLYTA, FANAPT, ARISTADA, Dyanavel XR, INGREZZA.

Industry payments across PA — which companies pay providers there.